Ports And Complications For Intraperitoneal Chemotherapy Delivery

We have collected information about Ports And Complications For Intraperitoneal Chemotherapy Delivery for you. Follow the links to find out details on Ports And Complications For Intraperitoneal Chemotherapy Delivery.


Ports and complications for intraperitoneal chemotherapy ...

    https://obgyn.onlinelibrary.wiley.com/doi/pdf/10.1111/j.1471-0528.2011.03179.x
    Intraperitoneal access ports are essential to the delivery of chemotherapy agents into the peritoneal cavity of women with ovarian cancer, but their malfunction and adverse effects are frequently responsible for the failure to complete planned therapy. Complications, such as obstruction of the catheter,Author: CW Helm

Ports and complications for intraperitoneal chemotherapy ...

    https://www.ncbi.nlm.nih.gov/pubmed/22017885
    Ports and complications for intraperitoneal chemotherapy delivery. Helm CW(1). Author information: (1)Division of Gynecologic Oncology, Department of Obstetrics and Gynecology and Women's Health, Saint Louis University School of Medicine, MO, USA. [email protected]: CW Helm

Ports and complications for intraperitoneal chemotherapy ...

    https://www.researchgate.net/publication/51740321_Ports_and_complications_for_intraperitoneal_chemotherapy_delivery
    Please cite this paper as: Helm C. Ports and complications for intraperitoneal chemotherapy delivery. BJOG 2012;119:150–159. Intraperitoneal access ports are essential to the delivery of ...

Ports and complications for intraperitoneal chemotherapy ...

    https://obgyn.onlinelibrary.wiley.com/doi/full/10.1111/j.1471-0528.2011.03179.x
    Oct 21, 2011 · Please cite this paper as: Helm C. Ports and complications for intraperitoneal chemotherapy delivery. BJOG 2012;119:150–159. Intraperitoneal access ports are essential to the delivery of chemotherapy agents into the peritoneal cavity of women with ovarian cancer, but their malfunction and adverse effects are frequently responsible for the failure to complete planned therapy.Author: CW Helm

Drug Delivery Systems for Intraperitoneal Therapy

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2854252/
    IP drug delivery helps in the regional therapy of these disorders by providing relatively high concentration and longer half-life of a drug in the peritoneal cavity. Various studies suggest that IP delivery of anti-neoplastic agents is a promising approach for malignancies in the peritoneal cavity compared to the systemic administration.Author: Gaurav Bajaj, Yoon Yeo

Searching for Ports And Complications For Intraperitoneal Chemotherapy Delivery?

You can just click the links above. The data is collected for you.

Related Delivery Info